4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0000947871-23-000628
Director bought 869,565 shares at $5.75 ($4,999,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2023-05-22 | Purchase | +869,565 | $5.75 | $4,999,999 | 10,119,756 | I |
| Open-market purchases · 869,565 sh · avg $5.75 · $4,999,999 | |||||||
Loading xslF345X04/ownership.xml…